ADAR1 Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

ADAR1 Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Buy	+49,923	New	+$703K	0.06%	152
2025 Q4	–	Sell	-28,023	Closed	-$198K	–	275
2025 Q3	$198K	Hold	28,023	–	–	0.02%	181
2025 Q2	$182K	Hold	28,023	–	–	0.03%	157
2025 Q1	$222K	Sell	28,023 -25,000	-47%	-$269K	0.04%	140
2024 Q4	$672K	Sell	53,023 -88	-0.2%	-$1.22K	0.13%	100
2024 Q3	$740K	Buy	53,111 +18,011	+51%	+$257K	0.12%	94
2024 Q2	$484K	Buy	+35,100	New	+$514K	0.09%	101

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

ADAR1 Capital Management's DAWN Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 49,923 shares worth $1.07M. The stake represents 0.06% of the portfolio and ranks #152 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in DAWN as recently as Q3 2025.

ADAR1 Capital Management first reported a position in DAWN in Q2 2024 and has held it in 7 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

ADAR1 Capital Management held 49,923 shares of Day One Biopharmaceuticals worth $1.07M as of Q1 2026.
Day One Biopharmaceuticals was a new ADAR1 Capital Management position in Q1 2026.
Day One Biopharmaceuticals made up 0.06% of ADAR1 Capital Management's portfolio in Q1 2026, its #152 holding.
ADAR1 Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2024 and has held it in 7 quarters since.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.